ITeos Therapeutics News

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gall Matthew

Mar 8 20:06 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Call Matthew

Mar 8 20:01 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McGrath Yvonne

Mar 8 20:01 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Detheux Michel

Mar 8 20:01 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DeSimone Jill

Mar 7 20:06 ET

ITeos Therapeutics | 3: Initial statement of beneficial ownership of securities-Director DeSimone Jill

Mar 7 20:01 ET

ITeos Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 6 07:23 ET

ITeos Therapeutics | 10-K: Annual report

Mar 6 07:13 ET

ITeos Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(5.4%),Oleg Nodelman(5.4%), etc.

Feb 16 12:57 ET

ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(3.5%),BVF Inc.(3.5%), etc.

Feb 14 09:47 ET

ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.17%)

Feb 13 22:48 ET

ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(11.9%)

Jan 23 00:00 ET

ITeos Therapeutics | 8-K: Current report

Jan 10 00:00 ET

ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(2.7%),Millennium Group Management LLC(2.7%), etc.

Jan 9 00:00 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McGrath Yvonne

Dec 7, 2023 20:22 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Call Matthew

Dec 7, 2023 20:22 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Gall Matthew

Dec 7, 2023 20:21 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Detheux Michel

Dec 7, 2023 20:20 ET

ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee David K

Dec 7, 2023 20:17 ET

ITeos Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Lee David K

Dec 7, 2023 20:16 ET